Skip to content
Analytical services
Medical Device Testing
ISO 18562-2 and 18562-3 testing
Nebulizer testing ISO 27427
Testing and determination of condensate according to ISO 18562-4
Laser diffraction testing according to ISO 13320
Inhaler/Nasal/Nebulizer
Cascade Impactor (APSD) testing
Delivered dose, Emitted dose and DUSA
Nasal device testing
Nebulizer testing
Laser diffraction testing of aerosol
Plume geometry / Spray pattern / Plume front velocity
Dissolution testing of the lung dose
Prediction of Lung Dose – In vitro in vivo correlation
Particle counters APS
Solubility and chemical quantification of APIs/drugs
Other Analytical techniques and instrumentation
Quality system
Advising
Development and Understanding of Dry Powder Formulations for Inhalation
Modeling of Lung Dose and Prediction of Exposure
Advising on biocompatibility of medical devices
Products
Anatomical Throat Models
Mimetikos Preludium™ Software
About us
The Team
News
Publications
Collaborations and Partners
Career
Privacy Policy
Contact
Menu
Analytical services
Medical Device Testing
ISO 18562-2 and 18562-3 testing
Nebulizer testing ISO 27427
Testing and determination of condensate according to ISO 18562-4
Laser diffraction testing according to ISO 13320
Inhaler/Nasal/Nebulizer
Cascade Impactor (APSD) testing
Delivered dose, Emitted dose and DUSA
Nasal device testing
Nebulizer testing
Laser diffraction testing of aerosol
Plume geometry / Spray pattern / Plume front velocity
Dissolution testing of the lung dose
Prediction of Lung Dose – In vitro in vivo correlation
Particle counters APS
Solubility and chemical quantification of APIs/drugs
Other Analytical techniques and instrumentation
Quality system
Advising
Development and Understanding of Dry Powder Formulations for Inhalation
Modeling of Lung Dose and Prediction of Exposure
Advising on biocompatibility of medical devices
Products
Anatomical Throat Models
Mimetikos Preludium™ Software
About us
The Team
News
Publications
Collaborations and Partners
Career
Privacy Policy
Contact
Publication: Formulation development part 2
Formulation development: Part 2, by Kyrre Thalberg, Adj Prof and Senior Adviser
The second part of this suite is published. A must if you develop dry powder inhaler formulations. Contact Kyrre if you want to know more.
https://www.e-digitaleditions.com/i/1475629-inh0822/23
?
